NCT03192137View on ClinicalTrials.gov

Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

260

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

April 17, 2019

Study Completion Date

April 17, 2019

Conditions

Inflammation and Pain Associated With Cataract Surgery

Interventions

DRUG

ISV-305

Dexamethasone in DuraSite® 2 twice daily for 16 days

OTHER

Vehicle

Vehicle twice daily for 16 days

Trial Locations (1)

38120

Clinical Research Center, Memphis

All Listed Sponsors

lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT03192137 - Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery | Biotech Hunter | Biotech Hunter